{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Community+Acquired+Infections&page=5", "query": { "condition": "Community Acquired Infections", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 137, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Community+Acquired+Infections&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Community+Acquired+Infections&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T15:44:59.758Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01756339", "title": "Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community-acquired Bacterial Pneumonia" ], "interventions": [ { "name": "Solithromycin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo to match solithromycin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Melinta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 860, "start_date": "2012-12", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2017-03-03", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 25, "location_summary": "Glendale, California • Los Angeles, California • Mission Hills, California + 18 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01756339" }, { "nct_id": "NCT06029933", "title": "Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Influenza", "Community-acquired Pneumonia", "Cardiovascular Events" ], "interventions": [ { "name": "Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)", "type": "BIOLOGICAL" }, { "name": "High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1500000, "start_date": "2023-08-17", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06029933" }, { "nct_id": "NCT01032824", "title": "Self-Managing HIV and Chronic Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV/AIDS" ], "interventions": [ { "name": "Individual Telephone Counseling Intervention", "type": "BEHAVIORAL" }, { "name": "Group Arm", "type": "OTHER" }, { "name": "Book Arm", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 452, "start_date": "2007-10", "completion_date": "2011-02", "has_results": false, "last_update_posted_date": "2017-10-13", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01032824" }, { "nct_id": "NCT01110421", "title": "A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia, Bacterial", "Community-Acquired Infections", "Nosocomial Infection", "Pneumonia, Ventilator-Associated" ], "interventions": [ { "name": "Cefepime placebo", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Doripenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 7, "start_date": "2010-12", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 4, "location_summary": "Little Rock, Arkansas • Cleveland, Ohio • Toledo, Ohio + 1 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110421" }, { "nct_id": "NCT01662258", "title": "Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Community-acquired Pneumonia" ], "interventions": [ { "name": "Point-of-Care diagnostic laboratory test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2012-10", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2016-04-19", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 5, "location_summary": "Louisville, Kentucky • Baltimore, Maryland • New York, New York + 2 more", "locations": [ { "city": "Louisville", "state": "Kentucky" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" }, { "city": "Akron", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01662258" }, { "nct_id": "NCT02891915", "title": "Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Cefdinir", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "6 Months to 71 Months" }, "enrollment_count": 385, "start_date": "2016-12-02", "completion_date": "2019-12-16", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Louisville, Kentucky + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02891915" }, { "nct_id": "NCT04064567", "title": "Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV/AIDS", "Pre-exposure Prophylaxis" ], "interventions": [ { "name": "PrEP-LINK", "type": "BEHAVIORAL" }, { "name": "Enhanced Standard of Care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2019-09-30", "completion_date": "2024-04-30", "has_results": true, "last_update_posted_date": "2025-06-08", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 7, "location_summary": "Little Rock, Arkansas • West Memphis, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04064567" }, { "nct_id": "NCT00035347", "title": "Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Community-Acquired Pneumonia (CAP)" ], "interventions": [ { "name": "IV azithromycin", "type": "DRUG" }, { "name": "ceftriaxone", "type": "DRUG" }, { "name": "oral azithromycin", "type": "DRUG" }, { "name": "IV levofloxacin", "type": "DRUG" }, { "name": "oral levofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2001-01", "completion_date": "2002-06", "has_results": false, "last_update_posted_date": "2017-03-10", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Long Beach, California • Sylmar, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Sylmar", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Columbus", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00035347" }, { "nct_id": "NCT00084071", "title": "Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "Tifacogin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2136, "start_date": "2004-05", "completion_date": "2008-07", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 51, "location_summary": "Mobile, Alabama • Loma Linda, California • Los Angeles, California + 48 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00084071" }, { "nct_id": "NCT02559310", "title": "Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community Acquired Pneumonia" ], "interventions": [ { "name": "lefamulin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nabriva Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 551, "start_date": "2015-09", "completion_date": "2017-05", "has_results": true, "last_update_posted_date": "2019-10-23", "last_synced_at": "2026-10-21T15:44:59.758Z", "location_count": 7, "location_summary": "Hazard, Kentucky • Shreveport, Louisiana • Minneapolis, Minnesota + 4 more", "locations": [ { "city": "Hazard", "state": "Kentucky" }, { "city": "Shreveport", "state": "Louisiana" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Butte", "state": "Montana" }, { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02559310" } ] }